Abstract:Display Selectivity for ~3 over oclP2Y2 GABA Receptors OMohammad Sayed Alam. Fumiyo Ozoe, Jia Huang, Fumio Matsumura*, and Yoshihisa Ozoe (Dept. Life Sci. Biotechnol., Fac. Life Environ. Sci., Shimane Univ., *Dept. Environ. Toxicol., Univ. Calif., Davis, USA) Ilrtroductiozs. Ionotropic Y-aminobutyric acid (GABA) receptors are widely distributed in the nerve tissues to mediate fast inhibitory neurotransmission, and the GABA receptors of insects are important targets for insect control chemicals. We have reported the synthesis and structure-activity relationships (SARs) of 4or 5-substituted 1-phenyl-1H-1,2,3-triazoles as insecticidal, noncompetitive antagonistsl). In the present study, we further synthesized 4,5-disubstituted phenyltrlazoles and examined the potencies of both monoand disubstituted phenyltriazoles in human P3 and oelP2Y2 GABA receptors. The hcmomeric ~3 receptor was used as an insect GABA receptor model, as the P3 subunit has high sequence similarity to the housefly GABA receptor subunit MdRdl in the putative antagonist-binding site, and the heteromeric ccl~2Y2 GABA receptor is the most abundant subtype in vertebrate brain. We discuss the selectivity and SARS of 1phenyl-1H-1,2,3-triazoles in P3 and ocl ~2Y2 GABA receptors. Materials ~~x~d MethodS. 4,5-Disubstituted 1-phenyl-lH-1,2,3-triazoles were mainly synthesized by the I ,3-dipolar cycloaddition between an azide and an appropriate alkyne. A total of 5 1 compounds, including monosubstituted analogues, were examined for their ability to inhibit the specific binding of [3H]4'-ethynyl-4-n-propylbicycloorthobenzoate (EBOB), a noncompetitive antagonist, to human ~3 and ocl~2y2 GABA receptors. The P3 and oclP2Y2 receptors were stably expressed in S2 and HEK-293 cells, respectively. Three-dimensional SAR analysis and homology modeling studies were performed using SYBYL ver. 7. I and MOE ver. 2006.08, respectively. ResultS and Discussion. 1-(2,6-Dichlor0-4-trifluoromethylphenyl)-1H-1,2,3-triazoles containing an n-propyl group at the 4-position and a chloromethyl, a hydroxymethyl, or a methyl group at the 5-position showed the highest level of affimity for both ~3 and ccl ~2y2 receptors. Most ofthe tested compounds showed higher affmity for the ~3 receptor than for the ocl~2Y2 receptor. Among 4,5disubstituted anlogues, the 4-n-propyl-5-ethyl analogue exhibited the highest (>1133-fold) selectivity for the ~3 receptor versus the o~lP2Y2 receptor, followed by the 4-n-propyl-5-methyl analogue of 1-(2,6-dibromo-4-trifluoromethylphenyl)-lH-1,2,3-triazole, which showed >671-fold selectivity. The combination of 2,6-dichloro and 4-trifluoromethyl substitutions on the phenyl group was also found to be important to exhibit high affinity for both ~3 and (xl~2Y2 receptors. Thus, an n-propyl at the 4-position and a chloromethyl group at the 5-position are optimized substituents as reg'arding high potency in the ~3 receptor (Ki = 660 pM), but in terms of selectivity, an ethyl group proved to be better than a chloromethyl group as the 5-substituent. l) Alam et al. : J. Ag7'ic. Food Chem. , 54, 1 361-1 372 (2006)

Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists

Selective A(3) Adenosine Receptor Antagonists: Water-Soluble 3, 5-Diacyl-1,2,4-trialkylpyridinium Salts and Their Oxidative Generation from Dihydropyridine Precursors.

Pyran Template Approach to the Design of Novel A3 Adenosine Receptor Antagonists

2-Substituted (N)-Methanocarba A3 Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization

2-Substituted -Methanocarba A3 Adenosine Receptor Agonists: In silico, in vitro and in vivo Characterization

Synthesis, 3D-QSAR, and Docking Studies of 1-Phenyl-1h-1,2,3-triazoles As Selective Antagonists for Β3 over Α1β2γ2 GABA Receptors

B 31 O Structure-Activity Relatiouships of 1-PheHryil-1 H-1 , 2 , 3-triazole Antagonists That Display Selectivity for ~ 3 over oclP 2 Y 2 GABA Receptors OMohammad

Molecular Modeling Studies of Human A3 Adenosine Antagonists: Structural Homology and Receptor Docking

Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists

Medicinal chemistry of adenosine A3 receptor ligands

Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261

Enantiomeric Recognition of Racemic 4-Aryl-1,4-dihydropyridine Derivatives Via Chiralpak Ad-H Stationary Phases

2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives

Synthesis of Adenosine Analogues with Indole Moiety As Human Adenosine A3 Receptor Ligands.

Novel 5-Hydroxytryptamine (5-HT3) Receptor Antagonists. III. Pharmacological Evaluations and Molecular Modeling Studies of Optically Active 4,5,6,7-Tetrahydro-1H-benzimidazole Derivatives.

Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists.

2,6-Diaryl-4-phenacylaminopyrimidines As Potent and Selective Adenosine A(2A) Antagonists with Reduced Herg Liability.

Structure−Activity Relationships of New 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-4-amine Derivatives as Allosteric Enhancers of the A<sub>3</sub>Adenosine Receptor

Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors

Synthesis of Alkyne Derivatives of a Novel Triazolopyrazine As A2A Adenosine Receptor Antagonists.